𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The lag between effectiveness and cost-effectiveness evidence of new drugs

✍ Scribed by Boyka Stoykova; Michael Drummond; Marco Barbieri; Jos Kleijnen

Publisher
Springer
Year
2003
Tongue
French
Weight
199 KB
Volume
4
Category
Article
ISSN
1618-7598

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Bayesian cost-effectiveness analysis wit
Bayesian cost-effectiveness analysis with two measures of effectiveness: the cost-effectiveness acceptability plane
✍ Miguel A. NegrΓ­n; Francisco J. VΓ‘zquez-Polo πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 263 KB πŸ‘ 1 views

Cost-effectiveness analysis (CEA) compares the costs and outcomes of two or more technologies. However, there is no consensus about which measure of effectiveness should be used in each analysis. Clinical researchers have to select an appropriate outcome for their purpose, and this choice can have d

The usefulness of average cost-effective
The usefulness of average cost-effectiveness ratios
✍ Eugene M. Laska; Morris Meisner; Carole Siegel πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 82 KB πŸ‘ 2 views

We demonstrate that average cost-effectiveness ratios (CERs) play an important role in the evaluation of the cost-effectiveness of treatments. Criticisms of the usefulness of CERs derive mostly from the context of resource allocation under a constrained budget in which some decisions are based on in

The cost-effectiveness of breast cancer
The cost-effectiveness of breast cancer screening
✍ Paul J. Van Der Maas; Harry J. De Koning; B. Martin Van Ineveld; Gerrit J. Van O πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 French βš– 728 KB

The costs and effects of different invitation schedules of breast cancer screening are compared. The effect estimates are based on trials from the USA, Sweden and the Netherlands. The cost estimates use registration data, file studies and organization charts. The calculations were performed with the